{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:01:05Z","timestamp":1788609665942,"version":"build-2803163510"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02458-x","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:16:13Z","timestamp":1771607773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Acid sphingomyelinase\/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target"],"prefix":"10.1007","volume":"49","author":[{"given":"Yuehong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2458_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105932","volume":"92","author":"R Campanilho-Marques","year":"2025","unstructured":"Campanilho-Marques, R., J.E. Fonseca, and P.M. Machado. 2025. Treatment of idiopathic inflammatory myopathies. Joint Bone Spine 92: 105932. https:\/\/doi.org\/10.1016\/j.jbspin.2025.105932.","journal-title":"Joint Bone Spine"},{"key":"2458_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer, A., N. Meyer, M. Schaeffer, et al. 2015. Incidence and prevalence of inflammatory myopathies: A systematic review. Rheumatology (Oxford, England) 54: 50\u201363. https:\/\/doi.org\/10.1093\/rheumatology\/keu289.","journal-title":"Rheumatology (Oxford, England)"},{"key":"2458_CR3","doi-asserted-by":"crossref","unstructured":"Gender differences in patient experience in idiopathic inflammatory myopathies. Subanalysis from the COVAD dataset | Modern Rheumatology | Oxford Academic. https:\/\/academic.oup.com\/mr\/article\/34\/4\/756\/7285588?login=false. Accessed 30 July 2025.","DOI":"10.1093\/mr\/road094"},{"key":"2458_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084301","volume":"23","author":"RG Kamperman","year":"2022","unstructured":"Kamperman, R.G., A.J. van der Kooi, M. de Visser, et al. 2022. Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: A focused review. International Journal of Molecular Sciences 23: 4301. https:\/\/doi.org\/10.3390\/ijms23084301.","journal-title":"International Journal of Molecular Sciences"},{"key":"2458_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/rir-2022-0001","volume":"3","author":"F Halilu","year":"2022","unstructured":"Halilu, F., and L. Christopher-Stine. 2022. Myositis-specific antibodies: Overview and clinical utilization. Rheumatology and Immunology Research 3: 1\u201310. https:\/\/doi.org\/10.2478\/rir-2022-0001.","journal-title":"Rheumatology and Immunology Research"},{"key":"2458_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","volume":"19","author":"T Khoo","year":"2023","unstructured":"Khoo, T., J. B. Lilleker, and BY-H. Thong et al. 2023. Epidemiology of the idiopathic inflammatory myopathies. Nature Reviews Rheumatology 19:695\u2013712. https:\/\/doi.org\/10.1038\/s41584-023-01033-0","journal-title":"Nature Reviews Rheumatology"},{"key":"2458_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-025-09047-0","volume":"68","author":"T Liu","year":"2025","unstructured":"Liu, T., B. Chen, G. Yin, and Q. Xie. 2025. Targeting B cells for the treatment of idiopathic inflammatory myopathy. Clinical Reviews in Allergy & Immunology 68: 40. https:\/\/doi.org\/10.1007\/s12016-025-09047-0.","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"2458_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug, G.C., J. Svensson, I.E. Lundberg, and M. Holmqvist. 2018. Mortality in idiopathic inflammatory myopathy: Results from a swedish nationwide population-based cohort study. Annals of the Rheumatic Diseases 77: 40\u201347. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211402.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2458_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.70143","volume":"16","author":"R Wang","year":"2025","unstructured":"Wang, R., W. Lin, Q. Xie, and G. Yin. 2025. Targeted therapy for idiopathic inflammatory myopathy. Journal of Cachexia, Sarcopenia and Muscle 16: e70143. https:\/\/doi.org\/10.1002\/jcsm.70143.","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"2458_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fmed.2019.00326","volume":"6","author":"B Hervier","year":"2019","unstructured":"Hervier, B., and Y. Uzunhan. 2019. Inflammatory myopathy-related interstitial lung disease: From pathophysiology to treatment. Frontiers in Medicine (Lausanne) 6: 326. https:\/\/doi.org\/10.3389\/fmed.2019.00326.","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"2458_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMc1506163","volume":"373","author":"AL Mammen","year":"2015","unstructured":"Mammen, A.L., and E. Tiniakou. 2015. Intravenous immune globulin for statin-triggered autoimmune myopathy. The New England Journal of Medicine 373: 1680\u20131682. https:\/\/doi.org\/10.1056\/NEJMc1506163.","journal-title":"The New England Journal of Medicine"},{"key":"2458_CR12","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1100\/tsw.2002.863","volume":"2","author":"RA Brodsky","year":"2002","unstructured":"Brodsky, R.A. 2002. High dose cyclophosphamide treatment for autoimmune disorders. The Scientific World JOURNAL 2: 1808\u20131815. https:\/\/doi.org\/10.1100\/tsw.2002.863.","journal-title":"The Scientific World JOURNAL"},{"key":"2458_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","volume":"78","author":"M Ahlmann","year":"2016","unstructured":"Ahlmann, M., and G. Hempel. 2016. The effect of cyclophosphamide on the immune system: Implications for clinical cancer therapy. Cancer Chemotherapy and Pharmacology 78:661\u2013671. https:\/\/doi.org\/10.1007\/s00280-016-3152-1","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"2458_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/bjh.12629","volume":"164","author":"HM Reeves","year":"2014","unstructured":"Reeves, H.M., and J.L. Winters. 2014. The mechanisms of action of plasma exchange. British Journal of Haematology 164: 342\u2013351. https:\/\/doi.org\/10.1111\/bjh.12629.","journal-title":"British Journal of Haematology"},{"key":"2458_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/WCO.0b013e3283311ddf","volume":"22","author":"SA Greenberg","year":"2009","unstructured":"Greenberg, S.A. 2009. Inflammatory myopathies: Disease mechanisms. Current Opinion in Neurology 22: 516\u2013523. https:\/\/doi.org\/10.1097\/WCO.0b013e3283311ddf.","journal-title":"Current Opinion in Neurology"},{"key":"2458_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/hsz-2015-0109","volume":"396","author":"J Kornhuber","year":"2015","unstructured":"Kornhuber, J., C. Rhein, C.P. M\u00fcller, and C. M\u00fchle. 2015. Secretory sphingomyelinase in health and disease. Biological Chemistry 396: 707\u2013736. https:\/\/doi.org\/10.1515\/hsz-2015-0109.","journal-title":"Biological Chemistry"},{"key":"2458_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01999-7","volume":"12","author":"C Zhuo","year":"2022","unstructured":"Zhuo, C., F. Zhao, H. Tian, et al. 2022. Acid sphingomyelinase\/ceramide system in schizophrenia: Implications for therapeutic intervention as a potential novel target. Translational Psychiatry 12: 260. https:\/\/doi.org\/10.1038\/s41398-022-01999-7.","journal-title":"Translational Psychiatry"},{"key":"2458_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0022-2275(20)40138-5","volume":"8","author":"PB Schneider","year":"1967","unstructured":"Schneider, P.B., and E.P. Kennedy. 1967. Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. Journal of Lipid Research 8: 202\u2013209.","journal-title":"Journal of Lipid Research"},{"key":"2458_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.33594\/000000021","volume":"52","author":"C Li","year":"2019","unstructured":"Li, C., A. Wang, and Y. Wu et al. 2019. Acid Sphingomyelinase-Ceramide system in bacterial infections. Cellular Physiology and Biochemistry 52:280\u2013301. https:\/\/doi.org\/10.33594\/000000021","journal-title":"Cellular Physiology and Biochemistry"},{"key":"2458_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm823","volume":"9","author":"H Grassm\u00e9","year":"2003","unstructured":"Grassm\u00e9, H., V. Jendrossek, A. Riehle, et al. 2003. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nature Medicine 9: 322\u2013330. https:\/\/doi.org\/10.1038\/nm823.","journal-title":"Nature Medicine"},{"key":"2458_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111610","volume":"139","author":"H Xiang","year":"2021","unstructured":"Xiang, H., S. Jin, F. Tan, et al. 2021. Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase. Biomedicine & Pharmacotherapy 139: 111610. https:\/\/doi.org\/10.1016\/j.biopha.2021.111610.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2458_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167260","volume":"1870","author":"S Scrima","year":"2024","unstructured":"Scrima, S., M. Lambrughi, M. Tiberti, et al. 2024. ASM variants in the spotlight: A structure-based atlas for unraveling pathogenic mechanisms in lysosomal acid sphingomyelinase. Biochimica et Biophysica Acta - Molecular Basis of Disease 1870: 167260. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167260.","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"2458_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13082","volume":"7","author":"Y-F Zhou","year":"2016","unstructured":"Zhou, Y.-F., M.C. Metcalf, S.C. Garman, et al. 2016. Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease. Nature Communications 7: 13082. https:\/\/doi.org\/10.1038\/ncomms13082.","journal-title":"Nature Communications"},{"key":"2458_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12196","volume":"7","author":"A Gorelik","year":"2016","unstructured":"Gorelik, A., K. Illes, L.X. Heinz, et al. 2016. Crystal structure of mammalian acid sphingomyelinase. Nature Communications 7: 12196. https:\/\/doi.org\/10.1038\/ncomms12196.","journal-title":"Nature Communications"},{"key":"2458_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1073\/pnas.0136947100","volume":"100","author":"VE Ahn","year":"2003","unstructured":"Ahn, V. E., K. F. Faull, and J. P. Whitelegge et al. 2003. Crystal structure of Saposin B reveals a dimeric shell for lipid binding. Proc Natl Acad Sci U S A 100:38\u201343. https:\/\/doi.org\/10.1073\/pnas.0136947100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2458_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112083","volume":"133","author":"N Zhang","year":"2024","unstructured":"Zhang, N., G. Wang, L. Yang, et al. 2024. Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM\/ceramide pathway. International Immunopharmacology 133: 112083. https:\/\/doi.org\/10.1016\/j.intimp.2024.112083.","journal-title":"International Immunopharmacology"},{"key":"2458_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0898-6568(99)00072-8","volume":"12","author":"RT Dobrowsky","year":"2000","unstructured":"Dobrowsky, R.T. 2000. Sphingolipid signalling domains floating on rafts or buried in caves? Cellular Signalling 12: 81\u201390. https:\/\/doi.org\/10.1016\/s0898-6568(99)00072-8.","journal-title":"Cellular Signalling"},{"key":"2458_CR28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","volume":"52","author":"SE Horvath","year":"2013","unstructured":"Horvath, S.E., and G. Daum. 2013. Lipids of mitochondria. Progress in Lipid Research 52: 590\u2013614. https:\/\/doi.org\/10.1016\/j.plipres.2013.07.002.","journal-title":"Progress in Lipid Research"},{"key":"2458_CR29","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1093\/hmg\/ddaa248","volume":"29","author":"L Weiss","year":"2021","unstructured":"Weiss, L., K-M. Jung, and A. Nalbandian et al. 2021. Ceramide contributes to pathogenesis and May be targeted for therapy in VCP inclusion body myopathy. Human Molecular Genetics 29:3945\u20133953. https:\/\/doi.org\/10.1093\/hmg\/ddaa248","journal-title":"Human Molecular Genetics"},{"key":"2458_CR30","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1096\/fj.08-108043","volume":"22","author":"EL Smith","year":"2008","unstructured":"Smith, E.L., and E.H. Schuchman. 2008. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB Journal 22: 3419\u20133431. https:\/\/doi.org\/10.1096\/fj.08-108043.","journal-title":"FASEB Journal"},{"key":"2458_CR31","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.1021\/ja4059876","volume":"135","author":"JM Wadsworth","year":"2013","unstructured":"Wadsworth, J.M., D.J. Clarke, S.A. McMahon, et al. 2013. The chemical basis of serine palmitoyltransferase inhibition by myriocin. Journal of the American Chemical Society 135: 14276\u201314285. https:\/\/doi.org\/10.1021\/ja4059876.","journal-title":"Journal of the American Chemical Society"},{"key":"2458_CR32","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.12331","volume":"34","author":"K Kurek","year":"2014","unstructured":"Kurek, K., D. M. Piotrowska, and P. Wiesio\u0142ek-Kurek et al. 2014. Inhibition of ceramide de Novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver International : official Journal of the International Association for the Study of the Liver 34:1074\u20131083. https:\/\/doi.org\/10.1111\/liv.12331","journal-title":"Liver International : official Journal of the International Association for the Study of the Liver"},{"key":"2458_CR33","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1021\/jm301879g","volume":"56","author":"D Pizzirani","year":"2013","unstructured":"Pizzirani, D., C. Pagliuca, N. Realini, et al. 2013. Discovery of a new class of highly potent inhibitors of acid ceramidase: Synthesis and structure-activity relationship (SAR). Journal of Medicinal Chemistry 56: 3518\u20133530. https:\/\/doi.org\/10.1021\/jm301879g.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2458_CR34","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cellsig.2009.01.026","volume":"21","author":"RW Jenkins","year":"2009","unstructured":"Jenkins, R.W., D. Canals, and Y.A. Hannun. 2009. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cellular Signalling 21: 836\u2013846. https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.026.","journal-title":"Cellular Signalling"},{"key":"2458_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/s1388-1981(02)00335-9","volume":"1585","author":"DK Perry","year":"2002","unstructured":"Perry, D.K. 2002. Serine palmitoyltransferase: Role in apoptotic de novo ceramide synthesis and other stress responses. Biochimica et Biophysica Acta 1585: 146\u2013152. https:\/\/doi.org\/10.1016\/s1388-1981(02)00335-9.","journal-title":"Biochimica et Biophysica Acta"},{"key":"2458_CR36","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani, K., J. Idkowiak-Baldys, and Y. A. Hannun. 2008. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cellular Signalling 20:1010\u20131018. https:\/\/doi.org\/10.1016\/j.cellsig.2007.12.006","journal-title":"Cellular Signalling"},{"key":"2458_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010229","volume":"15","author":"I Alexandropoulou","year":"2023","unstructured":"Alexandropoulou, I., M.G. Grammatikopoulou, K.K. Gkouskou, et al. 2023. Ceramides in autoimmune rheumatic diseases: Existing evidence and therapeutic considerations for diet as an anticeramide treatment. Nutrients 15: 229. https:\/\/doi.org\/10.3390\/nu15010229.","journal-title":"Nutrients"},{"key":"2458_CR38","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","volume":"277","author":"AH Merrill","year":"2002","unstructured":"Merrill, A.H. 2002. De novo sphingolipid biosynthesis: A necessary, but dangerous, pathway. Journal of Biological Chemistry 277: 25843\u201325846. https:\/\/doi.org\/10.1074\/jbc.R200009200.","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun, Y.A., and L.M. Obeid. 2018. Sphingolipids and their metabolism in physiology and disease. Nature Reviews. Molecular Cell Biology 19: 175\u2013191. https:\/\/doi.org\/10.1038\/nrm.2017.107.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"2458_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.plipres.2007.03.001","volume":"46","author":"A Kihara","year":"2007","unstructured":"Kihara, A., S. Mitsutake, Y. Mizutani, and Y. Igarashi. 2007. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Progress in Lipid Research 46:126\u2013144. https:\/\/doi.org\/10.1016\/j.plipres.2007.03.001","journal-title":"Progress in Lipid Research"},{"key":"2458_CR41","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1038\/sj.onc.1207146","volume":"22","author":"E Gulbins","year":"2003","unstructured":"Gulbins, E., and R. Kolesnick. 2003. Raft ceramide in molecular medicine. Oncogene 22:7070\u20137077. https:\/\/doi.org\/10.1038\/sj.onc.1207146","journal-title":"Oncogene"},{"key":"2458_CR42","doi-asserted-by":"publisher","first-page":"30289","DOI":"10.1074\/jbc.M200494200","volume":"277","author":"H Grassm\u00e9","year":"2002","unstructured":"Grassm\u00e9, H., J. Bock, J. Kun, and E. Gulbins. 2002. Clustering of CD40 ligand is required to form a functional contact with CD40. Journal of Biological Chemistry 277:30289\u201330299. https:\/\/doi.org\/10.1074\/jbc.M200494200","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR43","doi-asserted-by":"publisher","first-page":"23954","DOI":"10.1074\/jbc.M101866200","volume":"276","author":"A Cremesti","year":"2001","unstructured":"Cremesti, A., F. Paris, H. Grassm\u00e9, et al. 2001. Ceramide enables fas to cap and kill. The Journal of Biological Chemistry 276: 23954\u201323961. https:\/\/doi.org\/10.1074\/jbc.M101866200.","journal-title":"The Journal of Biological Chemistry"},{"key":"2458_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41380-021-01309-5","volume":"27","author":"J Kornhuber","year":"2022","unstructured":"Kornhuber, J., N. Hoertel, and E. Gulbins. 2022. The acid sphingomyelinase\/ceramide system in COVID-19. Molecular Psychiatry 27:307\u2013314. https:\/\/doi.org\/10.1038\/s41380-021-01309-5","journal-title":"Molecular Psychiatry"},{"key":"2458_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00331","volume":"5","author":"N Beckmann","year":"2014","unstructured":"Beckmann, N., D. Sharma, E. Gulbins, et al. 2014. Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons. Frontiers in Physiology 5: 331. https:\/\/doi.org\/10.3389\/fphys.2014.00331.","journal-title":"Frontiers in Physiology"},{"key":"2458_CR46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40744-021-00301-3","volume":"8","author":"M Miao","year":"2021","unstructured":"Miao, M., Y. Li, B. Huang, et al. 2021. Treatment of active idiopathic inflammatory myopathies by low-dose interleukin-2: A prospective cohort pilot study. Rheumatology and Therapy 8: 835\u2013847. https:\/\/doi.org\/10.1007\/s40744-021-00301-3.","journal-title":"Rheumatology and Therapy"},{"key":"2458_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.757099","volume":"12","author":"Y Zhufeng","year":"2022","unstructured":"Zhufeng, Y., J. Xu, M. Miao, et al. 2022. Modification of intestinal microbiota dysbiosis by low-dose interleukin-2 in dermatomyositis: A post hoc analysis from a clinical trial study. Frontiers in Cellular and Infection Microbiology 12: 757099. https:\/\/doi.org\/10.3389\/fcimb.2022.757099.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"2458_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312870","volume":"22","author":"C Pinto","year":"2021","unstructured":"Pinto, C., D. Sousa, V. Ghilas, et al. 2021. Acid sphingomyelinase deficiency: A clinical and immunological perspective. International Journal of Molecular Sciences 22: 12870. https:\/\/doi.org\/10.3390\/ijms222312870.","journal-title":"International Journal of Molecular Sciences"},{"key":"2458_CR49","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/brain\/awm026","volume":"130","author":"V Mihaylova","year":"2007","unstructured":"Mihaylova, V., J. Hantke, and I. Sinigerska et al. 2007. Highly variable neural involvement in sphingomyelinase-deficient Niemann-Pick disease caused by an ancestral Gypsy mutation. Brain 130:1050\u20131061. https:\/\/doi.org\/10.1093\/brain\/awm026","journal-title":"Brain"},{"issue":"3","key":"2458_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1042\/bj3010855","volume":"301","author":"K Ferlinz","year":"1994","unstructured":"Ferlinz, K., R. Hurwitz, G. Vielhaber, et al. 1994. Occurrence of two molecular forms of human acid sphingomyelinase. Biochemical Journal 301 (3): 855\u2013862. https:\/\/doi.org\/10.1042\/bj3010855.","journal-title":"Biochemical Journal"},{"key":"2458_CR51","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1086\/503750","volume":"78","author":"CM Simonaro","year":"2006","unstructured":"Simonaro, C.M., J.-H. Park, E. Eliyahu, et al. 2006. Imprinting at the SMPD1 locus: Implications for acid sphingomyelinase-deficient Niemann-Pick disease. American Journal of Human Genetics 78: 865\u2013870. https:\/\/doi.org\/10.1086\/503750.","journal-title":"American Journal of Human Genetics"},{"key":"2458_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4049\/jimmunol.168.1.298","volume":"168","author":"H Grassm\u00e9","year":"2002","unstructured":"Grassm\u00e9, H., V. Jendrossek, J. Bock, et al. 2002. Ceramide-rich membrane rafts mediate CD40 clustering. Journal of Immunology (Baltimore, Md.\u202f: 1950) 168: 298\u2013307. https:\/\/doi.org\/10.4049\/jimmunol.168.1.298.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2458_CR53","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.4049\/jimmunol.1600691","volume":"197","author":"C Hollmann","year":"2016","unstructured":"Hollmann, C., S. Werner, E. Avota, et al. 2016. Inhibition of acid sphingomyelinase allows for selective targeting of CD4\u2009+\u2009conventional versus Foxp3\u2009+\u2009regulatory T cells. Journal of Immunology (Baltimore, Md.\u202f: 1950) 197: 3130\u20133141. https:\/\/doi.org\/10.4049\/jimmunol.1600691.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2458_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ni.1757","volume":"10","author":"J Herz","year":"2009","unstructured":"Herz, J., J. Pardo, H. Kashkar, et al. 2009. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nature Immunology 10: 761\u2013768. https:\/\/doi.org\/10.1038\/ni.1757.","journal-title":"Nature Immunology"},{"key":"2458_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0304-3940(98)00657-0","volume":"254","author":"CC Yang","year":"1998","unstructured":"Yang, C.C., V. Askanas, W.K. Engel, and R.B. Alvarez. 1998. Immunolocalization of transcription factor NF-\u03baB in inclusion-body myositis muscle and at normal human neuromuscular junctions. Neuroscience Letters 254: 77\u201380. https:\/\/doi.org\/10.1016\/s0304-3940(98)00657-0.","journal-title":"Neuroscience Letters"},{"key":"2458_CR56","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1016\/j.bbadis.2018.08.040","volume":"1864","author":"F Pierucci","year":"2018","unstructured":"Pierucci, F., A. Frati, C. Battistini, et al. 2018. Involvement of released sphingosine 1-phosphate\/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy. Biochimica et Biophysica Acta - Molecular Basis of Disease 1864: 3598\u20133614. https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.040.","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"2458_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09654-4","volume":"10","author":"S Dadsena","year":"2019","unstructured":"Dadsena, S., S. Bockelmann, J.G.M. Mina, et al. 2019. Ceramides bind VDAC2 to trigger mitochondrial apoptosis. Nature Communications 10: 1832. https:\/\/doi.org\/10.1038\/s41467-019-09654-4.","journal-title":"Nature Communications"},{"key":"2458_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellsig.2017.02.001","volume":"33","author":"C Niaudet","year":"2017","unstructured":"Niaudet, C., S. Bonnaud, M. Guillonneau, et al. 2017. Plasma membrane reorganization links acid sphingomyelinase\/ceramide to p38 MAPK pathways in endothelial cells apoptosis. Cellular Signalling 33: 10\u201321. https:\/\/doi.org\/10.1016\/j.cellsig.2017.02.001.","journal-title":"Cellular Signalling"},{"key":"2458_CR59","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","volume":"1788","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y., X. Li, K.A. Becker, and E. Gulbins. 2009. Ceramide-enriched membrane domains\u2013structure and function. Biochimica et Biophysica Acta 1788: 178\u2013183. https:\/\/doi.org\/10.1016\/j.bbamem.2008.07.030.","journal-title":"Biochimica et Biophysica Acta"},{"key":"2458_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0968-0004(00)88961-6","volume":"20","author":"YA Hannun","year":"1995","unstructured":"Hannun, Y.A., and L.M. Obeid. 1995. Ceramide: An intracellular signal for apoptosis. Trends in Biochemical Sciences 20: 73\u201377. https:\/\/doi.org\/10.1016\/s0968-0004(00)88961-6.","journal-title":"Trends in Biochemical Sciences"},{"key":"2458_CR61","doi-asserted-by":"publisher","unstructured":"Kolesnick, R.N., F.M. Go\u00f1i, and A. Alonso. 2000. Compartmentalization of ceramide signaling: Physical foundations and biological effects. Journal of Cellular Physiology 184: 285\u2013300. https:\/\/doi.org\/10.1002\/1097-4652(200009)184:3%253C285::AID-JCP2%253E3.0.CO;2-3.","DOI":"10.1002\/1097-4652(200009)184:3%253C285::AID-JCP2%253E3.0.CO;2-3."},{"key":"2458_CR62","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1021\/ja017807r","volume":"124","author":"TA Nurminen","year":"2002","unstructured":"Nurminen, T.A., J.M. Holopainen, H. Zhao, and P.K.J. Kinnunen. 2002. Observation of topical catalysis by sphingomyelinase coupled to microspheres. Journal of the American Chemical Society 124: 12129\u201312134. https:\/\/doi.org\/10.1021\/ja017807r.","journal-title":"Journal of the American Chemical Society"},{"key":"2458_CR63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.chom.2017.05.001","volume":"21","author":"H Grassm\u00e9","year":"2017","unstructured":"Grassm\u00e9, H., B. Henry, R. Ziobro, et al. 2017. \u03b21-integrin accumulates in Cystic Fibrosis luminal airway epithelial membranes and decreases sphingosine, promoting bacterial infections. Cell Host & Microbe 21: 707-718.e8. https:\/\/doi.org\/10.1016\/j.chom.2017.05.001.","journal-title":"Cell Host & Microbe"},{"key":"2458_CR64","doi-asserted-by":"publisher","first-page":"26256","DOI":"10.1074\/jbc.M500835200","volume":"280","author":"H Grassm\u00e9","year":"2005","unstructured":"Grassm\u00e9, H., A. Riehle, B. Wilker, and E. Gulbins. 2005. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. Journal of Biological Chemistry 280:26256\u201326262. https:\/\/doi.org\/10.1074\/jbc.M500835200","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR65","doi-asserted-by":"publisher","unstructured":"Henry, B., R. Ziobro, and K. A. Becker et al. 2013. Acid Sphingomyelinase. Handbook of Experimental Pharmacology 77\u201388. https:\/\/doi.org\/10.1007\/978-3-7091-1368-4_4","DOI":"10.1007\/978-3-7091-1368-4_4"},{"key":"2458_CR66","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1093\/emboj\/18.19.5252","volume":"18","author":"M Heinrich","year":"1999","unstructured":"Heinrich, M., M. Wickel, and W. Schneider-Brachert et al. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. Embo Journal 18:5252\u20135263. https:\/\/doi.org\/10.1093\/emboj\/18.19.5252","journal-title":"Embo Journal"},{"key":"2458_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1096\/fj.00-0370fje","volume":"15","author":"A Huwiler","year":"2001","unstructured":"Huwiler, A., B. Johansen, A. Skarstad, and J. Pfeilschifter. 2001. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. The FASEB Journal 15: 7\u20139. https:\/\/doi.org\/10.1096\/fj.00-0370fje.","journal-title":"The FASEB Journal"},{"key":"2458_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0092-8674(00)80183-x","volume":"89","author":"Y Zhang","year":"1997","unstructured":"Zhang, Y., B. Yao, S. Delikat, et al. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89: 63\u201372. https:\/\/doi.org\/10.1016\/s0092-8674(00)80183-x.","journal-title":"Cell"},{"key":"2458_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151337","volume":"102","author":"J Alizadeh","year":"2023","unstructured":"Alizadeh, J., S.C. da Silva Rosa, X. Weng, et al. 2023. Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy. European Journal of Cell Biology 102: 151337. https:\/\/doi.org\/10.1016\/j.ejcb.2023.151337.","journal-title":"European Journal of Cell Biology"},{"key":"2458_CR70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2010.06.030","volume":"147","author":"WPR Verdurmen","year":"2010","unstructured":"Verdurmen, W.P.R., M. Thanos, I.R. Ruttekolk, et al. 2010. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: Implications for uptake. Journal of Controlled Release 147: 171\u2013179. https:\/\/doi.org\/10.1016\/j.jconrel.2010.06.030.","journal-title":"Journal of Controlled Release"},{"key":"2458_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000623","volume":"5","author":"E Gassert","year":"2009","unstructured":"Gassert, E., E. Avota, H. Harms, et al. 2009. Induction of membrane ceramides: A novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression. PLoS Pathogens 5: e1000623. https:\/\/doi.org\/10.1371\/journal.ppat.1000623.","journal-title":"PLoS Pathogens"},{"key":"2458_CR72","doi-asserted-by":"publisher","first-page":"20589","DOI":"10.1074\/jbc.M101207200","volume":"276","author":"H Grassme","year":"2001","unstructured":"Grassme, H., A. Jekle, A. Riehle, et al. 2001. CD95 signaling via ceramide-rich membrane rafts. The Journal of Biological Chemistry 276: 20589\u201320596. https:\/\/doi.org\/10.1074\/jbc.M101207200.","journal-title":"The Journal of Biological Chemistry"},{"key":"2458_CR73","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mito.2006.03.002","volume":"6","author":"LJ Siskind","year":"2006","unstructured":"Siskind, L.J., R.N. Kolesnick, and M. Colombini. 2006. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6: 118\u2013125. https:\/\/doi.org\/10.1016\/j.mito.2006.03.002.","journal-title":"Mitochondrion"},{"key":"2458_CR74","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1089\/ars.2007.1509","volume":"9","author":"AY Zhang","year":"2007","unstructured":"Zhang, A.Y., F. Yi, S. Jin, et al. 2007. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxidants & Redox Signaling 9: 817\u2013828. https:\/\/doi.org\/10.1089\/ars.2007.1509.","journal-title":"Antioxidants & Redox Signaling"},{"key":"2458_CR75","doi-asserted-by":"publisher","first-page":"32744","DOI":"10.1074\/jbc.M303022200","volume":"278","author":"H Qiu","year":"2003","unstructured":"Qiu, H., T. Edmunds, and J. Baker-Malcolm et al. 2003. Activation of human acid Sphingomyelinase through modification or deletion of C-terminal cysteine. Journal of Biological Chemistry 278:32744\u201332752. https:\/\/doi.org\/10.1074\/jbc.M303022200","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR76","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.bbamem.2015.07.013","volume":"1848","author":"K-T Chang","year":"2015","unstructured":"Chang, K.-T., A. Anishkin, G.A. Patwardhan, et al. 2015. Ceramide channels: Destabilization by Bcl-xL and role in apoptosis. Biochimica et Biophysica Acta 1848: 2374\u20132384. https:\/\/doi.org\/10.1016\/j.bbamem.2015.07.013.","journal-title":"Biochimica et Biophysica Acta"},{"key":"2458_CR77","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland, W.L., B.T. Bikman, L.-P. Wang, et al. 2011. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. The Journal of Clinical Investigation 121: 1858\u20131870. https:\/\/doi.org\/10.1172\/JCI43378.","journal-title":"The Journal of Clinical Investigation"},{"key":"2458_CR78","unstructured":"Neutrophil Extracellular Traps and Its Implications in Inflammation. An Overview - PMC. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5292617\/. Accessed 2 Aug 2025."},{"key":"2458_CR79","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.0701354104","volume":"104","author":"Y Ramu","year":"2007","unstructured":"Ramu, Y., Y. Xu, and Z. Lu. 2007. Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin. Proceedings of the National Academy of Sciences of the United States of America 104: 6448\u20136453. https:\/\/doi.org\/10.1073\/pnas.0701354104.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2458_CR80","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2004.09.134","volume":"324","author":"Y Ito","year":"2004","unstructured":"Ito, Y., S. Sato, T. Ohashi, et al. 2004. Reduction of airway anion secretion via CFTR in sphingomyelin pathway. Biochemical and Biophysical Research Communications 324: 901\u2013908. https:\/\/doi.org\/10.1016\/j.bbrc.2004.09.134.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2458_CR81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","volume":"54","author":"BM Castro","year":"2014","unstructured":"Castro, B.M., M. Prieto, and L.C. Silva. 2014. Ceramide: A simple sphingolipid with unique biophysical properties. Progress in Lipid Research 54: 53\u201367. https:\/\/doi.org\/10.1016\/j.plipres.2014.01.004.","journal-title":"Progress in Lipid Research"},{"key":"2458_CR82","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgr\u00e4ber","year":"2008","unstructured":"Teichgr\u00e4ber, V., M. Ulrich, N. Endlich, et al. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nature Medicine 14: 382\u2013391. https:\/\/doi.org\/10.1038\/nm1748.","journal-title":"Nature Medicine"},{"key":"2458_CR83","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fcell.2019.00378","volume":"7","author":"C Li","year":"2019","unstructured":"Li, C., S. Guo, W. Pang, and Z. Zhao. 2019. Crosstalk between acid sphingomyelinase and inflammasome signaling and their emerging roles in tissue injury and fibrosis. Frontiers in Cell and Developmental Biology 7: 378. https:\/\/doi.org\/10.3389\/fcell.2019.00378.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"2458_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jhep.2014.09.023","volume":"62","author":"C Garcia-Ruiz","year":"2015","unstructured":"Garcia-Ruiz, C., J.M. Mato, D. Vance, et al. 2015. Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways. Journal of Hepatology 62: 219\u2013233. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.023.","journal-title":"Journal of Hepatology"},{"key":"2458_CR85","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jeu.12043","volume":"60","author":"EV Castro","year":"2013","unstructured":"Castro, E.V., K.G. Yoneyama, E.F. Haapalainen, et al. 2013. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes. Journal of Eukaryotic Microbiology 60: 377\u2013387. https:\/\/doi.org\/10.1111\/jeu.12043.","journal-title":"Journal of Eukaryotic Microbiology"},{"key":"2458_CR86","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1159\/000322342","volume":"26","author":"R Dhami","year":"2010","unstructured":"Dhami, R., X. He, and E. H. Schuchman. 2010. Acid Sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cellular Physiology and Biochemistry 26:749\u2013760. https:\/\/doi.org\/10.1159\/000322342","journal-title":"Cellular Physiology and Biochemistry"},{"key":"2458_CR87","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni, A., J. Sageshima, C. Wei, et al. 2011. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Science Translational Medicine 3: 85ra46. https:\/\/doi.org\/10.1126\/scitranslmed.3002231.","journal-title":"Science Translational Medicine"},{"key":"2458_CR88","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.celrep.2015.05.006","volume":"11","author":"LX Heinz","year":"2015","unstructured":"Heinz, L. X., C. L. Baumann, and M. S. K\u00f6berlin et al. 2015. The Lipid-Modifying enzyme SMPDL3B negatively regulates innate immunity. Cell Rep 11:1919\u20131928. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.006","journal-title":"Cell Rep"},{"key":"2458_CR89","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner, G.J. 2010. Rituximab: Mechanism of action. Seminars in Hematology 47: 115\u2013123. https:\/\/doi.org\/10.1053\/j.seminhematol.2010.01.011.","journal-title":"Seminars in Hematology"},{"key":"2458_CR90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5266","volume":"11","author":"DA Rosen","year":"2019","unstructured":"Rosen, D.A., S.M. Seki, A. Fern\u00e1ndez-Casta\u00f1eda, et al. 2019. Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Science Translational Medicine 11: eaau5266. https:\/\/doi.org\/10.1126\/scitranslmed.aau5266.","journal-title":"Science Translational Medicine"},{"key":"2458_CR91","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1043-6618(03)00052-5","volume":"47","author":"E Gulbins","year":"2003","unstructured":"Gulbins, E. 2003. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacological Research 47:393\u2013399. https:\/\/doi.org\/10.1016\/S1043-6618(03)00052-5","journal-title":"Pharmacological Research"},{"key":"2458_CR92","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbrc.2016.01.134","volume":"470","author":"N Mizutani","year":"2016","unstructured":"Mizutani, N., Y. Omori, Y. Kawamoto, et al. 2016. Resveratrol-induced transcriptional up-regulation of ASMase (SMPD1) of human leukemia and cancer cells. Biochemical and Biophysical Research Communications 470: 851\u2013856. https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.134.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2458_CR93","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.bbalip.2015.08.002","volume":"1851","author":"SW Wang","year":"2015","unstructured":"Wang, S.W., P. Hojabrpour, P. Zhang, et al. 2015. Regulation of ceramide generation during macrophage apoptosis by ASMase and de novo synthesis. Biochimica et Biophysica Acta 1851: 1482\u20131489. https:\/\/doi.org\/10.1016\/j.bbalip.2015.08.002.","journal-title":"Biochimica et Biophysica Acta"},{"key":"2458_CR94","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.4049\/jimmunol.1201976","volume":"191","author":"C-L Chen","year":"2013","unstructured":"Chen, C.-L., C.-F. Lin, S.-W. Wan, et al. 2013. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3\u03b2 and NF-\u03baB activation. Journal of Immunology (Baltimore, Md.\u202f: 1950) 191: 1744\u20131752. https:\/\/doi.org\/10.4049\/jimmunol.1201976.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2458_CR95","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/rheumatology\/keae096","volume":"63","author":"A Neves","year":"2024","unstructured":"Neves, A., L. Viveiros, V. Venturelli, and D.A. Isenberg. 2024. Where are we now in biologic drugs for myositis? Rheumatology (Oxford, England) 63: 2938\u20132947. https:\/\/doi.org\/10.1093\/rheumatology\/keae096.","journal-title":"Rheumatology (Oxford, England)"},{"key":"2458_CR96","doi-asserted-by":"publisher","first-page":"13795","DOI":"10.1073\/pnas.96.24.13795","volume":"96","author":"A Lepple-Wienhues","year":"1999","unstructured":"Lepple-Wienhues, A., C. Belka, T. Laun, et al. 1999. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proceedings of the National Academy of Sciences of the United States of America 96: 13795\u201313800. https:\/\/doi.org\/10.1073\/pnas.96.24.13795.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2458_CR97","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cellsig.2016.09.010","volume":"29","author":"J Jacobi","year":"2017","unstructured":"Jacobi, J., M. Garc\u00eda-Barros, S. Rao, et al. 2017. Targeting acid sphingomyelinase with anti-angiogenic chemotherapy. Cellular Signalling 29: 52\u201361. https:\/\/doi.org\/10.1016\/j.cellsig.2016.09.010.","journal-title":"Cellular Signalling"},{"key":"2458_CR98","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/antiox9121279","volume":"9","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar, E., and P. Muriel. 2020. Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants (Basel, Switzerland) 9: 1279. https:\/\/doi.org\/10.3390\/antiox9121279.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"2458_CR99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","volume":"559","author":"M K\u00f6lzer","year":"2004","unstructured":"K\u00f6lzer, M., N. Werth, and K. Sandhoff. 2004. Interactions of acid Sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant Desipramine. FEBS Letters 559: 96\u201398. https:\/\/doi.org\/10.1016\/S0014-5793(04)00033-X.","journal-title":"FEBS Letters"},{"key":"2458_CR100","doi-asserted-by":"publisher","first-page":"11549","DOI":"10.1074\/jbc.M609424200","volume":"282","author":"YH Zeidan","year":"2007","unstructured":"Zeidan, Y.H., and Y.A. Hannun. 2007. Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation. Journal of Biological Chemistry 282: 11549\u201311561. https:\/\/doi.org\/10.1074\/jbc.M609424200.","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR101","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/jm070524a","volume":"51","author":"J Kornhuber","year":"2008","unstructured":"Kornhuber, J., P. Tripal, and M. Reichel et al. 2008. Identification of new functional inhibitors of acid Sphingomyelinase using a structure-property-activity relation model. Journal of Medicinal Chemistry 51:219\u2013237. https:\/\/doi.org\/10.1021\/jm070524a","journal-title":"Journal of Medicinal Chemistry"},{"key":"2458_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1033-y","volume":"18","author":"I Loell","year":"2016","unstructured":"Loell, I., J. Raouf, Y.-W. Chen, et al. 2016. Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Research & Therapy 18: 136. https:\/\/doi.org\/10.1186\/s13075-016-1033-y.","journal-title":"Arthritis Research & Therapy"},{"key":"2458_CR103","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.2337\/db12-0029","volume":"61","author":"CR Bruce","year":"2012","unstructured":"Bruce, C.R., S. Risis, J.R. Babb, et al. 2012. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 61: 3148\u20133155. https:\/\/doi.org\/10.2337\/db12-0029.","journal-title":"Diabetes"},{"key":"2458_CR104","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/sur.2006.050","volume":"8","author":"J Cuschieri","year":"2007","unstructured":"Cuschieri, J., E. Bulger, J. Billgrin, et al. 2007. Acid sphingomyelinase is required for lipid raft TLR4 complex formation. Surgical Infections (Larchmont, N.Y.) 8: 91\u2013106. https:\/\/doi.org\/10.1089\/sur.2006.050.","journal-title":"Surgical Infections (Larchmont, N.Y.)"},{"key":"2458_CR105","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","volume":"158","author":"GF Nixon","year":"2009","unstructured":"Nixon, G.F. 2009. Sphingolipids in inflammation: Pathological implications and potential therapeutic targets. British Journal of Pharmacology 158: 982\u2013993. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00281.x.","journal-title":"British Journal of Pharmacology"},{"key":"2458_CR106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","volume":"61","author":"A Gomez-Mu\u00f1oz","year":"2016","unstructured":"Gomez-Mu\u00f1oz, A., N. Presa, A. Gomez-Larrauri, et al. 2016. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Progress in Lipid Research 61: 51\u201362. https:\/\/doi.org\/10.1016\/j.plipres.2015.09.002.","journal-title":"Progress in Lipid Research"},{"key":"2458_CR107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.18632\/aging.101719","volume":"11","author":"V Vozella","year":"2019","unstructured":"Vozella, V., A. Basit, F. Piras, et al. 2019. Elevated plasma ceramide levels in post-menopausal women: A cross-sectional study. Aging (Albany NY) 11: 73\u201388. https:\/\/doi.org\/10.18632\/aging.101719.","journal-title":"Aging (Albany NY)"},{"key":"2458_CR108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuron.2018.09.010","volume":"100","author":"MH Park","year":"2018","unstructured":"Park, M.H., J.Y. Lee, K.H. Park, et al. 2018. Vascular and neurogenic rejuvenation in aging mice by modulation of ASM. Neuron 100: 167-182.e9. https:\/\/doi.org\/10.1016\/j.neuron.2018.09.010.","journal-title":"Neuron"},{"key":"2458_CR109","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4149\/gpb_2015046","volume":"35","author":"NA Babenko","year":"2016","unstructured":"Babenko, N.A., V.V. Garkavenko, G.V. Storozhenko, and O.A. Timofiychuk. 2016. Role of acid sphingomyelinase in the age-dependent dysregulation of sphingolipids turnover in the tissues of rats. General Physiology and Biophysics 35: 195\u2013205. https:\/\/doi.org\/10.4149\/gpb_2015046.","journal-title":"General Physiology and Biophysics"},{"key":"2458_CR110","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-171054","volume":"63","author":"TA Couttas","year":"2018","unstructured":"Couttas, T.A., N. Kain, C. Tran, et al. 2018. Age-dependent changes to sphingolipid balance in the human Hippocampus are gender-specific and may sensitize to neurodegeneration. Journal of Alzheimer\u2019s Disease 63: 503\u2013514. https:\/\/doi.org\/10.3233\/JAD-171054.","journal-title":"Journal of Alzheimer's Disease"},{"key":"2458_CR111","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler, R.G., J. Kelly, K. Storie, et al. 2004. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences of the United States of America 101: 2070\u20132075. https:\/\/doi.org\/10.1073\/pnas.0305799101.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2458_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021817","volume":"6","author":"LJA Spijkers","year":"2011","unstructured":"Spijkers, L.J.A., R.F.P. van den Akker, B.J.A. Janssen, et al. 2011. Hypertension is associated with marked alterations in sphingolipid biology: A potential role for ceramide. PLoS One 6: e21817. https:\/\/doi.org\/10.1371\/journal.pone.0021817.","journal-title":"PLoS One"},{"key":"2458_CR113","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1124\/jpet.110.168815","volume":"334","author":"KM Boini","year":"2010","unstructured":"Boini, K.M., C. Zhang, M. Xia, et al. 2010. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. Journal of Pharmacology and Experimental Therapeutics 334: 839\u2013846. https:\/\/doi.org\/10.1124\/jpet.110.168815.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2458_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100719","volume":"66","author":"AG Ostermeyer-Fay","year":"2025","unstructured":"Ostermeyer-Fay, A.G., A. Kanodia, R. Pathak, et al. 2025. The steady-state level of plasma membrane ceramide is regulated by neutral sphingomyelinase 2. Journal of Lipid Research 66: 100719. https:\/\/doi.org\/10.1016\/j.jlr.2024.100719.","journal-title":"Journal of Lipid Research"},{"key":"2458_CR115","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1152\/ajpendo.00124.2015","volume":"309","author":"OS Kwon","year":"2015","unstructured":"Kwon, O. S., R. E. Tanner, and K. M. Barrows et al. 2015. MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance. American Journal of Physiology. Endocrinology and Metabolism 309:E11\u201321. https:\/\/doi.org\/10.1152\/ajpendo.00124.2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"2458_CR116","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","volume":"15","author":"JA Chavez","year":"2012","unstructured":"Chavez, J.A., and S.A. Summers. 2012. A ceramide-centric view of insulin resistance. Cell Metabolism 15: 585\u2013594. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.002.","journal-title":"Cell Metabolism"},{"key":"2458_CR117","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1042\/BJ20081149","volume":"417","author":"ML Watson","year":"2009","unstructured":"Watson, M.L., M. Coghlan, and H.S. Hundal. 2009. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells. Biochemical Journal 417: 791\u2013801. https:\/\/doi.org\/10.1042\/BJ20081149.","journal-title":"Biochemical Journal"},{"key":"2458_CR118","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/jgh.12291","volume":"28","author":"D Lizarazo","year":"2013","unstructured":"Lizarazo, D., V. Zabala, M. Tong, et al. 2013. Ceramide inhibitor myriocin restores insulin\/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. Journal of Gastroenterology and Hepatology 28: 1660\u20131668. https:\/\/doi.org\/10.1111\/jgh.12291.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"2458_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/srep01035","volume":"3","author":"N Realini","year":"2013","unstructured":"Realini, N., C. Solorzano, C. Pagliuca, et al. 2013. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Scientific Reports 3: 1035. https:\/\/doi.org\/10.1038\/srep01035.","journal-title":"Scientific Reports"},{"key":"2458_CR120","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun, Y.A., and L.M. Obeid. 2008. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nature Reviews. Molecular Cell Biology 9: 139\u2013150. https:\/\/doi.org\/10.1038\/nrm2329.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"2458_CR121","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10495-011-0589-x","volume":"16","author":"V Giansanti","year":"2011","unstructured":"Giansanti, V., A. Torriglia, and A. I. Scovassi. 2011. Conversation between apoptosis and autophagy: Is it your turn or mine? Apoptosis 16:321\u2013333. https:\/\/doi.org\/10.1007\/s10495-011-0589-x","journal-title":"Apoptosis"},{"issue":"Suppl","key":"2458_CR122","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","volume":"50","author":"N Bartke","year":"2009","unstructured":"Bartke, N., and Y.A. Hannun. 2009. Bioactive sphingolipids: Metabolism and function. Journal of Lipid Research 50 (Suppl): S91-96. https:\/\/doi.org\/10.1194\/jlr.R800080-JLR200.","journal-title":"Journal of Lipid Research"},{"key":"2458_CR123","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1021\/cr2002917","volume":"111","author":"AH Merrill","year":"2011","unstructured":"Merrill, A.H. 2011. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chemical Reviews 111: 6387\u20136422. https:\/\/doi.org\/10.1021\/cr2002917.","journal-title":"Chemical Reviews"},{"key":"2458_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-024-00347-1","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen, Y., H. Liu, Z. Luo, et al. 2024. ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4\u2009+\u2009T cells into Th17 and Treg subsets. Skeletal Muscle 14: 16. https:\/\/doi.org\/10.1186\/s13395-024-00347-1.","journal-title":"Skeletal Muscle"},{"key":"2458_CR125","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","volume":"52","author":"A Ceribelli","year":"2017","unstructured":"Ceribelli, A., M. De Santis, and N. Isailovic et al. 2017. The immune response and the pathogenesis of idiopathic inflammatory myositis: A critical review. Clinical Reviews in Allergy and Immunology 52:58\u201370. https:\/\/doi.org\/10.1007\/s12016-016-8527-x","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"2458_CR126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch, A., N. Schwab, T. Ruck, et al. 2010. FOXP3\u2009+\u2009T regulatory cells in idiopathic inflammatory myopathies. Journal of Neuroimmunology 225: 137\u2013142. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.03.013.","journal-title":"Journal of Neuroimmunology"},{"key":"2458_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.360","volume":"8","author":"A Bai","year":"2017","unstructured":"Bai, A., and Y. Guo. 2017. Acid sphingomyelinase mediates human CD4\u2009+\u2009T-cell signaling: Potential roles in T-cell responses and diseases. Cell Death & Disease 8: e2963. https:\/\/doi.org\/10.1038\/cddis.2017.360.","journal-title":"Cell Death & Disease"},{"key":"2458_CR128","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/cei.12475","volume":"179","author":"F Espinosa-Ortega","year":"2015","unstructured":"Espinosa-Ortega, F., D. G\u00f3mez-Martin, K. Santana-De Anda, et al. 2015. Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: Tilting the balance towards proinflammatory and pro-apoptotic subsets. Clinical and Experimental Immunology 179: 520\u2013528. https:\/\/doi.org\/10.1111\/cei.12475.","journal-title":"Clinical and Experimental Immunology"},{"key":"2458_CR129","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/rheumatology\/keab520","volume":"61","author":"JA Dvergsten","year":"2022","unstructured":"Dvergsten, J. A., A. M. Reed, and L. Landerman et al. 2022. Metabolomics analysis identifies a lipidomic profile in treatment-na\u00efve juvenile dermatomyositis patients vs healthy control subjects. Rheumatology (Oxford) 61:1699\u20131708. https:\/\/doi.org\/10.1093\/rheumatology\/keab520","journal-title":"Rheumatology (Oxford)"},{"key":"2458_CR130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2016.11.008","volume":"175","author":"Y Mao-Draayer","year":"2017","unstructured":"Mao-Draayer, Y., J. Sarazin, D. Fox, and E. Schiopu. 2017. The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. Clinical Immunology 175: 10\u201315. https:\/\/doi.org\/10.1016\/j.clim.2016.11.008.","journal-title":"Clinical Immunology"},{"key":"2458_CR131","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semcdb.2004.05.002","volume":"15","author":"T Hla","year":"2004","unstructured":"Hla, T. 2004. Physiological and pathological actions of sphingosine 1-phosphate. Seminars in Cell & Developmental Biology 15:513\u2013520. https:\/\/doi.org\/10.1016\/j.semcdb.2004.05.002","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"2458_CR132","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann, V., M.D. Davis, C.E. Heise, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. Journal of Biological Chemistry 277: 21453\u201321457. https:\/\/doi.org\/10.1074\/jbc.C200176200.","journal-title":"Journal of Biological Chemistry"},{"key":"2458_CR133","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nri1650","volume":"5","author":"H Rosen","year":"2005","unstructured":"Rosen, H., and E.J. Goetzl. 2005. Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network. Nature Reviews Immunology 5: 560\u2013570. https:\/\/doi.org\/10.1038\/nri1650.","journal-title":"Nature Reviews Immunology"},{"key":"2458_CR134","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/ni1523","volume":"8","author":"T Walzer","year":"2007","unstructured":"Walzer, T., L. Chiossone, J. Chaix, et al. 2007. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunology 8: 1337\u20131344. https:\/\/doi.org\/10.1038\/ni1523.","journal-title":"Nature Immunology"},{"key":"2458_CR135","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","volume":"398","author":"MP McGinley","year":"2021","unstructured":"McGinley, M.P., and J.A. Cohen. 2021. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet 398: 1184\u20131194. https:\/\/doi.org\/10.1016\/S0140-6736(21)00244-0.","journal-title":"Lancet"},{"key":"2458_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031280","volume":"22","author":"C Bernacchioni","year":"2021","unstructured":"Bernacchioni, C., V. Ghini, R. Squecco, et al. 2021. Role of Sphingosine 1-Phosphate signalling axis in muscle atrophy induced by TNF\u03b1 in C2C12 myotubes. International Journal of Molecular Sciences 22: 1280. https:\/\/doi.org\/10.3390\/ijms22031280.","journal-title":"International Journal of Molecular Sciences"},{"key":"2458_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103738","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Q. Lin, H. Cheng, et al. 2025. Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications. Autoimmunity Reviews 24: 103738. https:\/\/doi.org\/10.1016\/j.autrev.2024.103738.","journal-title":"Autoimmunity Reviews"},{"key":"2458_CR138","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/BOR.0000000000000831","volume":"33","author":"C Franco","year":"2021","unstructured":"Franco, C., M. Gatto, L. Iaccarino, et al. 2021. Lymphocyte immunophenotyping in inflammatory myositis: A review. Current Opinion in Rheumatology 33: 522\u2013528. https:\/\/doi.org\/10.1097\/BOR.0000000000000831.","journal-title":"Current Opinion in Rheumatology"},{"key":"2458_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.573347","volume":"11","author":"AC Bonomo","year":"2020","unstructured":"Bonomo, A.C., F. Pinto-Mariz, I. Riederer, et al. 2020. Crosstalk between innate and T cell adaptive immunity with(in) the muscle. Frontiers in Physiology 11: 573347. https:\/\/doi.org\/10.3389\/fphys.2020.573347.","journal-title":"Frontiers in Physiology"},{"key":"2458_CR140","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13317-014-0062-2","volume":"5","author":"G Vattemi","year":"2014","unstructured":"Vattemi, G., M. Mirabella, V. Guglielmi, et al. 2014. Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis. Autoimmunity Highlights 5: 77\u201385. https:\/\/doi.org\/10.1007\/s13317-014-0062-2.","journal-title":"Autoimmunity Highlights"},{"key":"2458_CR141","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4137\/CMAMD.S10272","volume":"5","author":"Y Shimojima","year":"2012","unstructured":"Shimojima, Y., W. Ishii, M. Matsuda, and S.-I. Ikeda. 2012. Phenotypes of peripheral blood lymphocytes and cytokine expression in polymyositis and dermatomyositis before treatment and after clinical remission. Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders 5: 77\u201387. https:\/\/doi.org\/10.4137\/CMAMD.S10272.","journal-title":"Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders"},{"key":"2458_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-3-13","volume":"3","author":"S Rayavarapu","year":"2013","unstructured":"Rayavarapu, S., W. Coley, T.B. Kinder, and K. Nagaraju. 2013. Idiopathic inflammatory myopathies: Pathogenic mechanisms of muscle weakness. Skeletal Muscle 3: 13. https:\/\/doi.org\/10.1186\/2044-5040-3-13.","journal-title":"Skeletal Muscle"},{"key":"2458_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.579043","volume":"11","author":"W-C Wu","year":"2020","unstructured":"Wu, W.-C., S.-J. Song, Y. Zhang, and X. Li. 2020. Role of extracellular vesicles in autoimmune pathogenesis. Frontiers in Immunology 11: 579043. https:\/\/doi.org\/10.3389\/fimmu.2020.579043.","journal-title":"Frontiers in Immunology"},{"key":"2458_CR144","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-065x.1994.tb00846.x","volume":"138","author":"RA Kroczek","year":"1994","unstructured":"Kroczek, R.A., D. Graf, D. Brugnoni, et al. 1994. Defective expression of CD40 ligand on T cells causes \u201cX-linked immunodeficiency with hyper-IgM (HIGM1).\u201d Immunological Reviews 138: 39\u201359. https:\/\/doi.org\/10.1111\/j.1600-065x.1994.tb00846.x.","journal-title":"Immunological Reviews"},{"key":"2458_CR145","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.7679801","volume":"259","author":"RC Allen","year":"1993","unstructured":"Allen, R.C., R.J. Armitage, M.E. Conley, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990\u2013993. https:\/\/doi.org\/10.1126\/science.7679801.","journal-title":"Science"},{"key":"2458_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11837-2","volume":"7","author":"H-Y Chung","year":"2017","unstructured":"Chung, H.-Y., C.J. Witt, N. Jbeily, et al. 2017. Acid sphingomyelinase inhibition prevents development of sepsis sequelae in the murine liver. Scientific Reports 7: 12348. https:\/\/doi.org\/10.1038\/s41598-017-11837-2.","journal-title":"Scientific Reports"},{"key":"2458_CR147","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2022.03.004","volume":"603","author":"H Zhang","year":"2022","unstructured":"Zhang, H., F. He, L. Zhou, et al. 2022. Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-\u03baB pathways in experimental autoimmune myositis mice. Biochemical and Biophysical Research Communications 603: 29\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.004.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2458_CR148","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0014-5793(01)02977-5","volume":"507","author":"C Mazi\u00e8re","year":"2001","unstructured":"Mazi\u00e8re, C., M-A. Conte, and J-C. Mazi\u00e8re. 2001. Activation of the JAK\/STAT pathway by ceramide in cultured human fibroblasts. FEBS Letters 507:163\u2013168. https:\/\/doi.org\/10.1016\/S0014-5793(01)02977-5","journal-title":"FEBS Letters"},{"key":"2458_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04369-z","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen, X., Y. Ji, R. Liu, et al. 2023. Mitochondrial dysfunction: Roles in skeletal muscle atrophy. Journal of Translational Medicine 21: 503. https:\/\/doi.org\/10.1186\/s12967-023-04369-z.","journal-title":"Journal of Translational Medicine"},{"key":"2458_CR150","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","volume":"249","author":"A Baek","year":"2012","unstructured":"Baek, A., H.J. Park, S.-J. Na, et al. 2012. The expression of BAFF in the muscles of patients with dermatomyositis. Journal of Neuroimmunology 249: 96\u2013100. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.006.","journal-title":"Journal of Neuroimmunology"},{"key":"2458_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02412-8","volume":"23","author":"J Young-Glazer","year":"2021","unstructured":"Young-Glazer, J., A. Cisneros, E.M. Wilfong, et al. 2021. Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients. Arthritis Research & Therapy 23: 33. https:\/\/doi.org\/10.1186\/s13075-020-02412-8.","journal-title":"Arthritis Research & Therapy"},{"key":"2458_CR152","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson, S.E., J. Lee, and A.B. Goldfine. 2006. Inflammation and insulin resistance. Journal of Clinical Investigation 116: 1793\u20131801. https:\/\/doi.org\/10.1172\/JCI29069.","journal-title":"Journal of Clinical Investigation"},{"key":"2458_CR153","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.physbeh.2007.11.049","volume":"94","author":"NA van Herpen","year":"2008","unstructured":"van Herpen, N.A., and V.B. Schrauwen-Hinderling. 2008. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiology & Behavior 94: 231\u2013241. https:\/\/doi.org\/10.1016\/j.physbeh.2007.11.049.","journal-title":"Physiology & Behavior"},{"key":"2458_CR154","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han, J., and R. J. Kaufman. 2016. The role of ER stress in lipid metabolism and lipotoxicity. Journal of Lipid Research 57:1329\u20131338. https:\/\/doi.org\/10.1194\/jlr.R067595","journal-title":"Journal of Lipid Research"},{"key":"2458_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103308","volume":"22","author":"MG Danieli","year":"2023","unstructured":"Danieli, M.G., E. Antonelli, M.A. Piga, et al. 2023. Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies. Autoimmunity Reviews 22: 103308. https:\/\/doi.org\/10.1016\/j.autrev.2023.103308.","journal-title":"Autoimmunity Reviews"},{"key":"2458_CR156","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2014.06.009","volume":"61","author":"R Fucho","year":"2014","unstructured":"Fucho, R., L. Mart\u00ednez, and A. Baulies et al. 2014. ASMase regulates autophagy and lysosomal membrane permeabilization and its Inhibition prevents early stage non-alcoholic steatohepatitis. Journal of Hepatology 61:1126\u20131134. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.009","journal-title":"Journal of Hepatology"},{"key":"2458_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00132","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang, H., F. He, M. Shi, et al. 2017. Toll-like receptor 4-myeloid differentiation primary response gene 88 pathway is involved in the inflammatory development of polymyositis by mediating interferon-\u03b3 and interleukin-17A in humans and experimental autoimmune myositis mouse model. Frontiers in Neurology 8: 132. https:\/\/doi.org\/10.3389\/fneur.2017.00132.","journal-title":"Frontiers in Neurology"},{"key":"2458_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107810","volume":"98","author":"M Ma","year":"2021","unstructured":"Ma, M., K. Chai, and R. Deng. 2021. Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy. International Immunopharmacology 98: 107810. https:\/\/doi.org\/10.1016\/j.intimp.2021.107810.","journal-title":"International Immunopharmacology"},{"key":"2458_CR159","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J., Y. Zhao, K. Wang, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526: 660\u2013665. https:\/\/doi.org\/10.1038\/nature15514.","journal-title":"Nature"},{"key":"2458_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-022-00459-w","volume":"23","author":"F Liu","year":"2022","unstructured":"Liu, F., Y. Zhang, Y. Shi, et al. 2022. Ceramide induces pyroptosis through TXNIP\/NLRP3\/GSDMD pathway in HUVECs. BMC Molecular and Cell Biology 23: 54. https:\/\/doi.org\/10.1186\/s12860-022-00459-w.","journal-title":"BMC Molecular and Cell Biology"},{"key":"2458_CR161","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1933719108317583","volume":"15","author":"O Guzeloglu-Kayisli","year":"2008","unstructured":"Guzeloglu-Kayisli, O., G. Halis, S. Taskiran, et al. 2008. DNA-binding ability of NF-kappaB is affected differently by ERalpha and ERbeta and its activation results in inhibition of estrogen responsiveness. Reproductive Sciences 15: 493\u2013505. https:\/\/doi.org\/10.1177\/1933719108317583.","journal-title":"Reproductive Sciences"},{"key":"2458_CR162","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2014-207172","volume":"74","author":"AP Lightfoot","year":"2015","unstructured":"Lightfoot, A.P., A. McArdle, M.J. Jackson, and R.G. Cooper. 2015. In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness? Annals of the Rheumatic Diseases 74: 1340\u20131346. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207172.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2458_CR163","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00401-017-1731-9","volume":"134","author":"A Meyer","year":"2017","unstructured":"Meyer, A., G. Laverny, Y. Allenbach, et al. 2017. IFN-\u03b2-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis. Acta Neuropathologica 134: 655\u2013666. https:\/\/doi.org\/10.1007\/s00401-017-1731-9.","journal-title":"Acta Neuropathologica"},{"key":"2458_CR164","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/imr.12838","volume":"294","author":"CM Weyand","year":"2020","unstructured":"Weyand, C.M., and J.J. Goronzy. 2020. Immunometabolism in the development of rheumatoid arthritis. Immunological Reviews 294: 177\u2013187. https:\/\/doi.org\/10.1111\/imr.12838.","journal-title":"Immunological Reviews"},{"key":"2458_CR165","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cmet.2019.06.016","volume":"30","author":"Y Li","year":"2019","unstructured":"Li, Y., Y. Shen, K. Jin, et al. 2019. The DNA repair nuclease MRE11A functions as a mitochondrial protector and prevents T cell pyroptosis and tissue inflammation. Cell Metabolism 30: 477-492.e6. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.016.","journal-title":"Cell Metabolism"},{"key":"2458_CR166","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/ars.2013.5383","volume":"19","author":"MJ Jackson","year":"2013","unstructured":"Jackson, M.J. 2013. Interactions between reactive oxygen species generated by contractile activity and aging in skeletal muscle? Antioxidants & Redox Signaling 19: 804\u2013812. https:\/\/doi.org\/10.1089\/ars.2013.5383.","journal-title":"Antioxidants & Redox Signaling"},{"key":"2458_CR167","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","volume":"47","author":"Y Liu","year":"2014","unstructured":"Liu, Y., H. Yin, M. Zhao, and Q. Lu. 2014. TLR2 and TLR4 in autoimmune diseases: A comprehensive review. Clinical Reviews in Allergy and Immunology 47:136\u2013147. https:\/\/doi.org\/10.1007\/s12016-013-8402-y","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"2458_CR168","doi-asserted-by":"publisher","first-page":"E853","DOI":"10.1152\/ajpendo.00251.2013","volume":"305","author":"J Jin","year":"2013","unstructured":"Jin, J., X. Zhang, and Z. Lu et al. 2013. Acid Sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages. American Journal of Physiology. Endocrinology and Metabolism 305:E853\u2013867. https:\/\/doi.org\/10.1152\/ajpendo.00251.2013","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"2458_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116824","volume":"235","author":"RE Elshaer","year":"2019","unstructured":"Elshaer, R.E., M.K. Tawfik, N. Nosseir, et al. 2019. Leflunomide-induced liver injury in mice: Involvement of TLR4 mediated activation of PI3K\/mTOR\/NF\u03baB pathway. Life Sciences 235: 116824. https:\/\/doi.org\/10.1016\/j.lfs.2019.116824.","journal-title":"Life Sciences"},{"key":"2458_CR170","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molimm.2021.12.012","volume":"142","author":"E Wen","year":"2022","unstructured":"Wen, E., G. Xin, W. Su, et al. 2022. Activation of TLR4 induces severe acute pancreatitis-associated spleen injury via ROS-disrupted mitophagy pathway. Molecular Immunology 142: 63\u201375. https:\/\/doi.org\/10.1016\/j.molimm.2021.12.012.","journal-title":"Molecular Immunology"},{"key":"2458_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104426","volume":"369","author":"LA Kotze","year":"2021","unstructured":"Kotze, L.A., V.N. Leukes, Z. Fang, et al. 2021. Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis. Cellular Immunology 369: 104426. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104426.","journal-title":"Cellular Immunology"},{"key":"2458_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00524","volume":"10","author":"LM Webb","year":"2019","unstructured":"Webb, L.M., J. Narvaez Miranda, S.A. Amici, et al. 2019. NF-\u03baB\/mTOR\/MYC axis drives PRMT5 protein induction after T cell activation via transcriptional and non-transcriptional mechanisms. Frontiers in Immunology 10: 524. https:\/\/doi.org\/10.3389\/fimmu.2019.00524.","journal-title":"Frontiers in Immunology"},{"key":"2458_CR173","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2020.09.034","volume":"533","author":"M Zhang","year":"2020","unstructured":"Zhang, M., S. Zhao, C. Xu, et al. 2020. Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p\/TLR4 signaling axis. Biochemical and Biophysical Research Communications 533: 429\u2013436. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.034.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2458_CR174","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ebiom.2018.08.035","volume":"35","author":"M Zhou","year":"2018","unstructured":"Zhou, M., W. Xu, J. Wang, et al. 2018. Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-\u03baB pathway quenches intestinal inflammation and oxidative stress injury. EBioMedicine 35: 345\u2013360. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.035.","journal-title":"EBioMedicine"},{"key":"2458_CR175","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41423-019-0281-6","volume":"17","author":"W Zhang","year":"2020","unstructured":"Zhang, W., N. Zhuang, and X. Liu et al. 2020. The metabolic regulator Lamtor5 suppresses inflammatory signaling via regulating mTOR-mediated TLR4 degradation. Cellular & Molecular Immunology 17:1063\u20131076. https:\/\/doi.org\/10.1038\/s41423-019-0281-6","journal-title":"Cellular & Molecular Immunology"},{"key":"2458_CR176","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/BOR.0000000000000748","volume":"32","author":"M Loredo Martinez","year":"2020","unstructured":"Loredo Martinez, M., S. Zampieri, C. Franco, et al. 2020. Nonimmune mechanisms in idiopathic inflammatory myopathies. Current Opinion in Rheumatology 32: 515\u2013522. https:\/\/doi.org\/10.1097\/BOR.0000000000000748.","journal-title":"Current Opinion in Rheumatology"},{"key":"2458_CR177","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3262384","volume":"2017","author":"G Yin","year":"2017","unstructured":"Yin, G., Y. Wang, X.-M. Cen, et al. 2017. Identification of palmitoleic acid controlled by mTOR signaling as a biomarker of polymyositis. Journal of Immunology Research 2017: 3262384. https:\/\/doi.org\/10.1155\/2017\/3262384.","journal-title":"Journal of Immunology Research"},{"key":"2458_CR178","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/imr.12796","volume":"291","author":"DR Myers","year":"2019","unstructured":"Myers, D.R., B. Wheeler, and J.P. Roose. 2019. mTOR and other effector kinase signals that impact T cell function and activity. Immunological Reviews 291: 134\u2013153. https:\/\/doi.org\/10.1111\/imr.12796.","journal-title":"Immunological Reviews"},{"key":"2458_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040355","volume":"8","author":"T Moeller","year":"2019","unstructured":"Moeller, T., S. Wolfheimer, A. Goretzki, et al. 2019. NF\u03baB- and MAP-kinase signaling contribute to the activation of murine myeloid dendritic cells by a flagellin A:allergen fusion protein. Cells 8: 355. https:\/\/doi.org\/10.3390\/cells8040355.","journal-title":"Cells"},{"key":"2458_CR180","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00109-012-0968-y","volume":"91","author":"X Li","year":"2013","unstructured":"Li, X., W.-Q. Han, K.M. Boini, et al. 2013. TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: Evidence from ASM knockout mice. Journal of Molecular Medicine (Berlin, Germany) 91: 25\u201336. https:\/\/doi.org\/10.1007\/s00109-012-0968-y.","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"2458_CR181","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i2.102308","volume":"17","author":"H-N Wang","year":"2025","unstructured":"Wang, H.-N., Y. Wang, S.-Y. Zhang, and L. Bai. 2025. Emerging roles of the acid sphingomyelinase\/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications. World Journal of Cardiology 17: 102308. https:\/\/doi.org\/10.4330\/wjc.v17.i2.102308.","journal-title":"World Journal of Cardiology"},{"key":"2458_CR182","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.clbc.2025.03.011","volume":"25","author":"FCA de Moraes","year":"2025","unstructured":"de Moraes, F. C. A., V. K. T. Sano, and C. R. M. Pereira et al. 2025. Effects of AKT inhibitors for PIK3CA\/AKT1\/PTEN-Altered advanced or metastatic breast cancer: A Meta-Analysis of randomized clinical trials. Clinical Breast Cancer 25:391\u2013400e15. https:\/\/doi.org\/10.1016\/j.clbc.2025.03.011","journal-title":"Clinical Breast Cancer"},{"key":"2458_CR183","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.sajb.2025.03.004","volume":"180","author":"MdS Al Hasan","year":"2025","unstructured":"Al Hasan, MdS, MdS Bhuia, and R. Chowdhury et al. 2025. Anticancer activity of Jasminum sambac and its bioactive phytochemicals against the PI3K-AKT-mTOR pathway: A literature-based in Silico study. South African Journal of Botany 180:431\u2013443. https:\/\/doi.org\/10.1016\/j.sajb.2025.03.004","journal-title":"South African Journal of Botany"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:47:34Z","timestamp":1772851654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02458-x","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}